Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 4 | $86,148 |
Sells | 28 | $130,557 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
19 Mar 2025 16:03 | ESPR | Esperion Therapeutics Inc | HALLADAY BENJAMIN | Chief Financial Officer | 18 Mar 2025 | Sale | 3,535 | 1.483 | 5,242 | D |
19 Mar 2025 16:02 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 18 Mar 2025 | Sale | 2,433 | 1.487 | 3,618 | D |
19 Mar 2025 16:02 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 18 Mar 2025 | Sale | 13,047 | 1.504 | 19,623 | D |
20 Feb 2025 16:50 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Feb 2025 | Sale | 239 | 1.868 | 446 | D |
20 Feb 2025 16:50 | ESPR | Esperion Therapeutics Inc | HALLADAY BENJAMIN | Chief Financial Officer | 19 Feb 2025 | Sale | 11 | 1.86 | 20 | D |
21 Jan 2025 16:38 | ESPR | Esperion Therapeutics Inc | HALLADAY BENJAMIN | Chief Financial Officer | 17 Jan 2025 | Sale | 9 | 2.265 | 20 | D |
21 Jan 2025 16:37 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 Jan 2025 | Sale | 123 | 2.26 | 278 | D |
18 Dec 2024 16:14 | ESPR | Esperion Therapeutics Inc | HALLADAY BENJAMIN | Chief Financial Officer | 17 Dec 2024 | Sale | 3,245 | 2.424 | 7,866 | D |
18 Dec 2024 16:13 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 Dec 2024 | Sale | 2,234 | 2.429 | 5,426 | D |
18 Dec 2024 16:12 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 17 Dec 2024 | Sale | 12,447 | 2.466 | 30,694 | D |
20 Nov 2024 16:10 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Nov 2024 | Sale | 197 | 2.165 | 427 | D |
18 Oct 2024 16:08 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 Oct 2024 | Sale | 107 | 2.119 | 227 | D |
18 Sep 2024 16:12 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 17 Sep 2024 | Sale | 14,550 | 1.796 | 26,132 | D |
18 Sep 2024 16:11 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 Sep 2024 | Sale | 2,608 | 1.783 | 4,650 | D |
20 Aug 2024 16:03 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Aug 2024 | Sale | 211 | 1.946 | 411 | D |
19 Jul 2024 08:30 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 Jul 2024 | Sale | 108 | 2.587 | 279 | D |
19 Jul 2024 08:29 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 17 Jul 2024 | Sale | 917 | 2.599 | 2,383 | D |
20 Jun 2024 16:20 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 18 Jun 2024 | Sale | 3,285 | 2.867 | 9,418 | D |
20 Jun 2024 16:16 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 18 Jun 2024 | Sale | 2,540 | 2.856 | 7,254 | D |
20 May 2024 16:14 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 May 2024 | Sale | 192 | 2.483 | 477 | D |
21 Sep 2023 17:06 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 20 Sep 2023 | Sale | 742 | 1.245 | 924 | D |
21 Aug 2023 16:32 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 18 Aug 2023 | Sale | 243 | 1.414 | 344 | D |
20 Jul 2023 16:38 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Jul 2023 | Sale | 106 | 1.585 | 168 | D |
22 Jun 2023 16:45 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 21 Jun 2023 | Sale | 603 | 1.483 | 894 | D |
18 May 2023 16:07 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 17 May 2023 | Sale | 219 | 1.624 | 356 | D |
11 May 2023 16:11 | ESPR | Esperion Therapeutics Inc | CARROLL J MARTIN | Director | 11 May 2023 | Purchase | 23,091 | 1.5714 | 36,285 | D |
11 May 2023 16:11 | ESPR | Esperion Therapeutics Inc | CARROLL J MARTIN | Director | 10 May 2023 | Purchase | 8,409 | 1.4919 | 12,545 | D |
11 May 2023 16:10 | ESPR | Esperion Therapeutics Inc | ROCAMBOLI STEPHEN | Director | 10 May 2023 | Purchase | 8,111 | 1.495 | 12,126 | D |
10 May 2023 16:12 | ESPR | Esperion Therapeutics Inc | KOENIG SHELDON L. | President and CEO | 09 May 2023 | Purchase | 20,000 | 1.2596 | 25,192 | D |
20 Apr 2023 16:12 | ESPR | Esperion Therapeutics Inc | WARREN ERIC | Chief Commercial Officer | 19 Apr 2023 | Sale | 115 | 1.278 | 147 | D |
20 Apr 2023 16:12 | ESPR | Esperion Therapeutics Inc | LOOKER BENJAMIN | General Counsel | 19 Apr 2023 | Sale | 1,290 | 1.272 | 1,641 | D |
20 Apr 2023 16:11 | ESPR | Esperion Therapeutics Inc | FOODY JOANNE M. | Chief Medical Officer | 19 Apr 2023 | Sale | 938 | 1.271 | 1,192 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)